✦ LIBER ✦

Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study

✍ Scribed by Zinzani, Pier Luigi; Pellegrini, Cinzia; Merla, Emanuela; Ballerini, Filippo; Fabbri, Alberto; Guarini, Attilio; Pavone, Vincenzo; Quintini, Gerlando; Puccini, Benedetta; Vigliotti, Maria Luigia; Stefoni, Vittorio; Derenzini, Enrico; Broccoli, Alessandro; Gandolfi, Letizia; Quirini, Federica; Casadei, Beatrice; Argnani, Lisa; Baccarani, Michele

Book ID: 120486899
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 110 KB
Volume: 31
Category: Article
ISSN: 0278-0232
DOI: 10.1002/hon.2036

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Irinotecan-Cetuximab-Bevacizumab as a Sa

Irinotecan-Cetuximab-Bevacizumab as a Salvage Treatment in Heavily Pretreated Metastatic Colorectal Cancer Patients: A Retrospective Observational Study

✍ Feliu Batlle, J.; Cuadrado, E.; Castro, J.; Caldés, T.; Belda, C.; Sastre, J.; B 📂 Article 📅 2011 🏛 S. Karger AG 🌐 English ⚖ 291 KB

Trabectedin as single agent in the salva

Trabectedin as single agent in the salvage treatment of heavily treated ovarian cancer patients: A retrospective, multicenter study

✍ Ferrandina, Gabriella; Salutari, Vanda; Vincenzi, Bruno; Marinaccio, Marco; Nagl 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 337 KB

Bendamustine as salvage treatment for pa

Bendamustine as salvage treatment for patients with relapsed or refractory mantle cell lymphoma patients: a retrospective study of the Spanish experience

✍ A. García-noblejas; C. Martínez Chamorro; B. Navarro Matilla; C. Da Silva Rodrig 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 344 KB

Local experience with the novel human an

Local experience with the novel human anti-CD20 antibody, ofatumumab, as salvage treatment for patients with heavily pretreated chronic lymphocytic leukaemia

✍ C. Y. Cheah; D. A. Carney; S. M. Lim; H. Januszewicz; J. Scarlett; J. F. Seymour 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 763 KB

5.56 Ofatumumab in Combination with High

5.56 Ofatumumab in Combination with High-Dose Methylprednisolone as a Salvage Treatment for Heavily Pretreated or Refractory Patients with Chronic Lymphocytic Leukemia

✍ Juan S. Barajas-Gamboa; Julio A. Diaz-Perez; Lina M. Ariza-Serrano; John M. Hort 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 68 KB

Rituximab monotherapy with eight weekly

Rituximab monotherapy with eight weekly infusions for relapsed or refractory patients with indolent B cell non-Hodgkin lymphoma mostly pretreated with rituximab: A multicenter phase II study

✍ Kensei Tobinai; Tadahiko Igarashi; Kuniaki Itoh; Mitsutoshi Kurosawa; Hirokazu N 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB